S.Amdt. 3413Senate114th Congress (2015-2017)
S.Amdt. 3413
Sponsored by
Sen. Brian Schatz (D-HI)
Submitted March 2, 2016
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
March 2, 2016
View full timeline
Floor
Senate amendment submitted
March 2, 2016
Floor
Senate amendment submitted
March 2, 2016
Text
Submitted
SA 3413. Mr. SCHATZ (for himself, Mr. Hatch, Mr. Tester, Mr. Cochran, and Ms. Collins) submitted an amendment intended to be proposed by him to the bill S. 524, to authorize the Attorney General to award grants to address the national epidemics of prescription opioid abuse and heroin use; which was ordered to lie on the table; as follows: At the end of title I of the bill, add the following: SEC. 104. ENHANCING BASIC AND APPLIED RESEARCH ON PAIN TO DISCOVER THERAPIES, INCLUDING ALTERNATIVES TO OPIOIDS, FOR EFFECTIVE PAIN MANAGEMENT. (a) In General.--Out of any money appropriated to the National Institutes of Health (referred to in this section as the ``NIH'') not otherwise obligated, the Director of the NIH may intensify and coordinate fundamental, translational, and clinical research of the NIH with respect to-- (1) the understanding of pain; (2) the discovery and development of therapies for chronic pain; and (3) the development of alternatives to opioids for effective pain treatments. (b) Priority and Direction.--The prioritization and direction of the Federally funded portfolio of pain research studies shall consider recommendations made by the Interagency Pain Research Coordinating Committee in concert with the Pain Management Best Practices Inter-Agency Task Force, and in accordance with the National Pain Strategy, the Federal Pain Research Strategy, and the NIH-Wide Strategic Plan for Fiscal Years 2016-2020, the latter which calls for the relative burdens of individual diseases and medical disorders to be regarded as crucial considerations in balancing the priorities of the Federal research portfolio. ______